110 related articles for article (PubMed ID: 12924440)
1. Hypermethylation of the CDKN2/p16INK4A promotor in thyroid carcinogenesis.
Boltze C; Zack S; Quednow C; Bettge S; Roessner A; Schneider-Stock R
Pathol Res Pract; 2003; 199(6):399-404. PubMed ID: 12924440
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
3. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
5. Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma.
Ishida E; Nakamura M; Ikuta M; Shimada K; Matsuyoshi S; Kirita T; Konishi N
Oral Oncol; 2005 Jul; 41(6):614-22. PubMed ID: 15975525
[TBL] [Abstract][Full Text] [Related]
6. Alterations of p14ARF and p16INK4a genes in salivary gland carcinomas.
Nishimine M; Nakamura M; Kishi M; Okamoto M; Shimada K; Ishida E; Kirita T; Konishi N
Oncol Rep; 2003; 10(3):555-60. PubMed ID: 12684623
[TBL] [Abstract][Full Text] [Related]
7. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.
Schagdarsurengin U; Gimm O; Hoang-Vu C; Dralle H; Pfeifer GP; Dammann R
Cancer Res; 2002 Jul; 62(13):3698-701. PubMed ID: 12097277
[TBL] [Abstract][Full Text] [Related]
8. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
9. DNA hypermethylation status of multiple genes in papillary thyroid carcinomas.
Ishida E; Nakamura M; Shimada K; Higuchi T; Takatsu K; Yane K; Konishi N
Pathobiology; 2007; 74(6):344-52. PubMed ID: 18087199
[TBL] [Abstract][Full Text] [Related]
10. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
[TBL] [Abstract][Full Text] [Related]
13. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma.
Wang Y; Cheng J; Xu C; Liu S; Jiang S; Xu Q; Chen X; Zhuang H; Lu F
Liver Int; 2012 Mar; 32(3):420-8. PubMed ID: 22192146
[TBL] [Abstract][Full Text] [Related]
14. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma.
Li X; Hui AM; Sun L; Hasegawa K; Torzilli G; Minagawa M; Takayama T; Makuuchi M
Clin Cancer Res; 2004 Nov; 10(22):7484-9. PubMed ID: 15569978
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis.
Hsieh CJ; Klump B; Holzmann K; Borchard F; Gregor M; Porschen R
Cancer Res; 1998 Sep; 58(17):3942-5. PubMed ID: 9731506
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
[TBL] [Abstract][Full Text] [Related]
17. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
[TBL] [Abstract][Full Text] [Related]
18. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
19. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
Koscielny S; V Eggeling F; Dahse R
Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
[TBL] [Abstract][Full Text] [Related]
20. PTEN promoter methylation in sporadic thyroid carcinomas.
Alvarez-Nuñez F; Bussaglia E; Mauricio D; Ybarra J; Vilar M; Lerma E; de Leiva A; Matias-Guiu X;
Thyroid; 2006 Jan; 16(1):17-23. PubMed ID: 16487009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]